Clinical Trial Update: Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ketorolac for acute vaso-occlusive crisis in pediatric sickle cell disease; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• Toradol (ketorolac tromethamine)

Snippet

Sponsor: Children's Blood and Cancer Center at Dell Children's Medical Center | Conditions: Sickle Cell Disease, Sickle Cell Crisis | Phase 4 | Status: NOT_YET_RECRUITING